Lifemd, Inc. · NASDAQ:LFMD
Lifemd — Immudyne — Investor Presentation (December 2016)
28 slides from Lifemd's investor presentation, Dec 12, 2016
Slide 1: Immudyne Investor Presentation Q4 2016
IMMUDYNE Investor Presentation Q4 2016 www.immudyne.com (OTCQB: IMMD)
Slide 2: Safe Harbor
Safe Harbor Statements in this presentation that are not descriptions of historical facts are forward-looking statements relating to future events, and as such all forward-looking statements are made pursuant to the Securities Litigation Reform Act of 1995. Statements may contain certain forward-loo
Slide 3: Overview
Overview We are an innovative health and wellness company focused on developing & marketing consumer products that address large, unmet market needs Dermatologist endorsed, clinically ma) — | N @) te M studied skincare line containing Immudyne’s Beta-1/3,1/6 Glucan cosm Patented, dermatologist endor
Slide 4: Corporate Highlights
Corporate Highlights 70% top-line growth in 2015; 375% increase in revenue through Q3 2016 = Proven revenue and customer acquisition model = Strong cash position and conservative monthly overhead = Strong infrastructure for growth; key personnel in place to support exponential revenue growth = Meani
Slide 5: Our Business Has Turned the Corner with Accelerating Revenue Growth
Our Business Has Turned the Corner with Accelerating Revenue Growth 375% 0% 2014 2015 2016 IMMUDYNE °
Slide 6: Our Disciplined, Low Risk Growth Strategy
Our Disciplined, Low Risk Growth Strategy Leverage our expertise and infrastructure to prove out direct- response ROI Increase media spend and campaign scale with Drives low capital risk sustainable profitable growth over time Identify & build innovative brands in large markets IMMUDYNE
Slide 7: We Have Big Plans for 2017
We Have Big Plans for 2017 We are launching 2 patented, dermatologist backed product lines in January 2017 Relaunch of Inate Scientific product line as Inate MD; a complete, dermatologist backed skincare system Launch of Shapiro MD, a patented shampoo and conditioner for male and female hair loss Co
Slide 8: Playing in Large, Attractive Categories
Playing in Large, Attractive Categories... The market size for our current products is ~145B globally 2) $100 © s15 Skincare Hair-Loss Immuno-Therapy IMMUDYNE
Slide 9: Strong and Experienced Leadership Team
Strong and Experienced Leadership Team §) Mark McLaughlin, President & Chief Executive Officer \ - Former SVP at Oppenheimer & Co. and Lehman Brothers - Co-founder and Managing Partner at Cadbury Capital - Holds approximately 30% of Immudyne Common Stock Stefan Galluppi, Chief Operating Officer - Fo
Slide 10: Scientific Advisory Board
Scientific Advisory Board Steven D. Shapiro, M.D., Co-Founder of Shapiro MD - Board-Certified Dermatologist - Specializes in laser procedures & reconstructive skin cancer surgery - Chairman of the Board for Healthcare Underwriters' Group (HUG) Michael T. Borenstein, M.D., Ph.D., Co-Founder of Shapir
Slide 11: Immudyne Beta-1/3,1/6-Glucan
IMMUDYNG BETA-1/3,1/6-GLUCAN Sees CL
Slide 12: What is Beta-1/3,1/6-glucan?
What is Beta-1/3,1/6-glucan? = Beta- 1/3,1/6-glucan (“B-glucan”) is a safe and potent immune modulator derived from the cell wall of Baker’s yeast. It is the most studied natural immuno-modulator on earth. Natural polysaccharide that binds to the dectin-1, CR3, and TLR receptors found on immune cell
Slide 13: Broad Demand For Our Yeast Beta Glucan
Broad Demand For Our Yeast Beta Glucan Raw Material - Core ingredient in Inate MD - Direct sales to 3 of the top 5 serum, moisturizer and cosmetic companies in the world nutritional supplement - Used in medium to high end - Used in iNR Wellness nutritional skincare products found supplement for 24 h
Slide 14: iNR Wellness
INR Wellness Doctor Recommended Immune support Patented nutritional super-supplement containing Immudyne’s Beta-1/3,1/6 Glucan for daily Immune Support
Slide 15: Inate MD
nate MID Dermatologist endorsed, clinically studied skincare line containing Immudyne’s Beta-1/3,1/6 Glucan Now Endorsed by Dr. Lillian Ramirez. o 2017 International Marketing and Distribution campaign o. Reformulated for maximum efficacy and quality ° 74,000 units sold in 2016. Expected growth of 2
Slide 16: Skincare is a Large Category that Lacks Products Based on Real Science That Work
Skincare is a Large Category that Lacks Products Based on Real Science That Work Growing Skincare is fundamental Skin is the largest organ of the body and its 1° barrier providing protection against harsh environmental factors IMMUDYNE we
Slide 17: We Have Big Ambitions in Skincare
We Have Big Ambitions in Skincare N ro) pa a NO qe rag NS 74,000 units sold 200,000 units sold . . 40,000 customers 75,000 customers . . $6.8M in Revenue $15M in Revenue . . 7.8% Gross Profit 12%+ Gross Profit IMMUDYNE 17
Slide 18: Growth and Increased Profitability Fueled By
Growth and Increased Profitability Fueled By Improved Branding & Formulation - Products reformulated for maximum efficacy and quality - Improved branding on par with industry leading, high end brands Internalization of Media Buying - 2 full time employees devoted to acquiring media from Facebook, Go
Slide 19: Shapiro MD
SHAPIRO MD Steven Shapiro M.D. and Michael Borenstein M.D., P.h.D — Founders of Shapiro MD. IMMUDYNE
Slide 20: Hair-Loss is a Massive Category with Almost No Innovation or Scientific Advancement
Hair-Loss is a Massive Category with Almost No Innovation or Scientific Advancement a t Growing te +3.5% According to the American Hair Loss Association, 99% of products marketed to treat hair loss are completely ineffective. Shapiro MD contains the 3 most powerful, naturally occurring DHT blockers
Slide 21: There is a Huge Need in Hair Loss Category
There is a HUGE Need in Hair Loss Category = OTC product that is safe and beneficial for male & female hair loss = With shampooing and conditioning being a typical daily activity, it’s a “natural” to be well received by consumers = Consumers, especially those who typically do not use specialty produ
Slide 22: Shapiro MD Shampoo & Conditioner
Shapiro MD Shampoo & Conditioner Patented formulation containing 3 potent naturally occurring active ingredients that have been shown to be effective blocking dihydrotestosterone (DHT). DHT is a hormone that his widely believed to be the primary cause of hair loss. Caffeine EGCG SPBE Clinical studie
Slide 23: Shapiro MD... Results Coming in 2017
Shapiro MD... Results Coming in 2017 = Shapiro MD launch slated for Jan 2017 Before After 90 Days = Aggressive online direct-response marketing effort via Google, Facebook and native ad networks = National infomercial campaign already in the works with leading production firm = Strong domestic and i
Slide 24: Investment Summary
Investment Summary = Profitable & Growing. Immudyne is profitable and anticipates significant sales growth in FY2017. = Incredible Products. Our portfolio of products address large unmet needs and are backed by real science and accomplished medical opinion leaders. " Large Addressable Market. We bel
Slide 25: Investor Contact
IMMUDYNE OTCQB: IMMD Investor Contact: Mark McLaughlin, CEO markmcl@immudyne.com www.immudyne.com 25
Slide 26: Appendix
IMMUDYNE Appendix 26
Slide 27: Key Scientific Publications Of B-glucan
Key Scientific Publications Of B-glucan = Immune-Regulating Properties. /mmune-modulatory effects of dietary Yeast Beta- 1,3/1,6-D-glucan (Nutritional Journal, Stier et al) = Adjuvant For Cancer Therapy. Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal a
Slide 28: IMMD Board of Directors
IMMD Board of Directors = Mark McLaughlin, President & CEO, former SVP at Oppenheimer & Co., Lehman Brothers. Led Immudyne's commercial build-out, and turn-around to profitable biotech company. = Dr. Anthony Bruzzese, Chairman, Radiologist certified by the American Board of Internal Medicine and the